AstraZeneca | 6-K: Closure of Notes Sale Pursuant to Underwriting Agreement
Feb 26 16:10 ET
AstraZeneca | 20-F: Registration statement / Annual report / Transition report
Feb 20 22:15 ET
AstraZeneca | 6-K: Annual Financial Report
Feb 20 09:28 ET
AstraZeneca | 6-K: FY and Q4 2023 Results
Feb 8 06:45 ET
AstraZeneca | 6-K: 9M and Q3 2023 Results
Nov 9, 2023 09:49 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Jul 28, 2023 08:46 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 27, 2023 14:19 ET
AstraZeneca: FY2022 Annual Report
20-F | ASTRAZENECA PLC (0000901832) (Filer)
Feb 21, 2023 16:45 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 21, 2023 08:24 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 9, 2023 08:48 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 10, 2022 07:00 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Jul 29, 2022 07:59 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 29, 2022 06:39 ET
AstraZeneca | 20-F: FY2021 Annual Report
Feb 22, 2022 17:13 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 22, 2022 08:10 ET
AstraZeneca | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 10, 2022 06:15 ET
AstraZeneca | 20-F: FY2020 Annual Report
Feb 16, 2021 06:08 ET
AstraZeneca | 20-F: FY2019 Annual Report
Mar 3, 2020 16:21 ET
AstraZeneca | 20-F: FY2018 Annual Report
Mar 5, 2019 16:35 ET
AstraZeneca | 20-F: FY2017 Annual Report
Mar 6, 2018 16:51 ET
No Data
No Data